Abstract
Objective:
In this study, we evaluated the feasibility of using dynamic contrast-enhanced MRI (DCE-MRI) subtracted images as a predictor of a decrease in tumor volume in response to chemoradiotherapy in 13 patients with cervical cancer.
Conclusion:
This study shows that pretreatment tumor nonenhancing fraction assessed with arterial image subtraction inversely predicts the chemoradiation response in cervical cancer.
MeSH terms
-
Adult
-
Chemotherapy, Adjuvant*
-
Contrast Media
-
Female
-
Gadolinium DTPA*
-
Humans
-
Image Enhancement / methods*
-
Magnetic Resonance Imaging / methods*
-
Middle Aged
-
Prognosis
-
Radiotherapy, Adjuvant*
-
Reproducibility of Results
-
Sensitivity and Specificity
-
Subtraction Technique*
-
Treatment Outcome
-
Uterine Cervical Neoplasms / diagnosis*
-
Uterine Cervical Neoplasms / therapy*
-
Young Adult
Substances
-
Contrast Media
-
Gadolinium DTPA